Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

Critical Care

Volumn 11, Issue 6, 2007, Pages

  Lutterloh, Emily C ^a   Opal, Steven M ^a   Pittman, Debra D ^b   Keith Jr , James C ^b   Tan, Xiang Yang ^b   Clancy, Brian M ^b   Palmer, Helen ^b   Milarski, Kim ^b   Sun, Ying ^b   Palardy, John E ^a   Parejo, Nicholas A ^a   Kessimian, Noubar ^a  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; MONOCLONAL ANTIBODY; RECEPTOR ADVANCED GLYCATION END PRODUCT MAB ANTIBODY; UNCLASSIFIED DRUG; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM COLONY; CONTROLLED STUDY; DRUG EFFICACY; INFECTION RESISTANCE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; MOUSE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; SURVIVAL RATE; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; METABOLISM; MORTALITY; MOUSE MUTANT; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; GLYCOSYLATION END PRODUCTS, ADVANCED; LISTERIA INFECTIONS; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; SEPSIS; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 37749005803     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6184     Document Type: Article

References (24)

1. Rice TW Bernard GR Therapeutic intervention and targets for sepsis Annu Rev Med 2005, 56:225-248. 10.1146/annurev.med.56.082103.104356 15660511
2. Cross AS Opal SM A new paradigm for the treatment of sepsis: Is it time to consider combination therapy? Ann Intern Med 2003, 138:502-505. 12639085
3. Neeper M Schmidt AM Brett J Yan SD Wang F Pan YCE Elliston K Stern D Shaw A Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 1992, 267:14998-15004. 1378843
4. Schmidt AM Vianna M Gerlach M Brett J Ryan J Kao J Esposito C Hegarty H Hurley W Clauss M Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface J Biol Chem 1992, 267:14987-14997. 1321822
5. Schmidt AM Yan SD Yan SF Stern DM The biology of the receptor for advanced glycation end products and its ligands Biochim Biophys Acta 2000, 1498:99-111. 10.1016/S0167-4889(00)00087-2 11108954
6. Hofmann MA Drury S Fu C Qu W Taguchi A Lu Y Avila C Kambham N Bierhaus A Nawroth P RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/calgranulin polypeptides Cell 1999, 97:889-901. 10.1016/S0092-8674(00)80801-6 10399917
7. Lalla E Lamster IB Feit M Huang L Spessot A Qu W Kislinger T Lu Y Stern DM Schmidt AM Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice J Clin Invest 2000, 105:1117-1124. 300834 10772656
8. Hofmann MA Drury S Hudson BI Gleason MR Qu W Lu Y Lalla E Chitnis S Monteiro J Stickland MH RAGE and arthritis: The G82S polymorphism amplifies the inflammatory response Genes Immun 2002, 3:123-135. 10.1038/ sj.gene.6363861 12070776
9. Chavakis T Bierhaus A Al-Fakhri N Schneider D Witte S Linn T Nagashima M Morser J Arnold B Preissner KT The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment J Exp Med 2003, 198:1507-1515. 10.1084/ jem.20030800 14623906
10. Basta G Lazzerini G Massaro M Simoncini T Tanganelli P Fu C Kislinger T Stern DM Schmidt AM De Caterina R Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: A mechanism for amplification of inflammatory responses Circulation 2002, 105:816-822. 10.1161/hc0702.104183 11854121
11. Tanji N Markowitz GS Fu C Kislinger T Taguchi A Pischetsrieder M Stern D Schmidt AM D'Agati VD Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease J Am Soc Nephrol 2000, 11:1656-1666. 10966490
12. Hori O Brett J Slattery T Cao R Zhang J Chen JX Nagashima M Lundh ER Vijay S Nitecki D The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem 1995, 270:25752-25761. 10.1074/ jbc.270.43.25752 7592757
13. Yan SD Zhu H Zhu A Golabek A Du H Roher A Yu J Soto C Schmidt AM Stern D Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis Nat Med 2000, 6:643-651. 10.1038/76216 10835680
14. Seong S-Y Matzinger P Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses Nat Rev Immunol 2004, 4:469-478. 10.1038/nri1372 15173835
15. Harris HE Raucci A Alarmin(g) news about danger EMBO Rep 2006, 7:774-778. 1525157 16858429
16. Park JS Svetkauskaite D He Q Kim JY Strassheim D Ishizaka A Abraham E Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 2004, 279:7370-7377. 10.1074/jbc.M306793200 14660645
17. Yang H Ochani M Li J Qiang X Tanovic M Harris HE Susarla SM Ulloa L Wang H DiRaimo R Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci USA 2004, 101:296-301. 314179 14695889 10.1073/pnas.2434651100
18. Treutiger CJ Mullins GE Johansson A-SM Rouhiainen A Rauvala HME Erlandsson-Harris H Andersson U Yang H Tracey KJ High mobility group 1 B-box mediates activation of human endothelium J Intern Med 2003, 254:375-385. 10.1046/j.1365-2796.2003.01204.x 12974876
19. Liliensiek B Weigand MA Beirhaus A Nicklas W Kasper M Hofer S Plachky J Gröne HJ Kurschus FC Schmidt AM Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 2004, 113:1641-1650. 419481 15173891 10.1172/JCI200418704
20. Echtenacher B Falk W Männel DN Krammer PH Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis J Immunol 1990, 145:3762-3766. 2246512
21. Schmidt AM Yan SD Yan SF Stern DM The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J Clin Invest 2001, 108:949-955. 200958 11581294 10.1172/JCI200114002
22. Bucciarelli LG Wendt T Rong L Lalla E Hofmann MA Goova MT Taguchi A Yan SF Yan SD Stern DM RAGE is a multiligand receptor of the immunoglobulin superfamily: Implications for homeostasis and chronic disease Cell Mol Life Sci 2002, 59:1117-1128. 10.1007/s00018-002-8491-x 12222959
23. Mackaness GB Cellular resistance to infection J Exp Med 1962, 116:381-406. 10.1084/jem.116.3.381 14467923
24. Wing EJ Gregory SH Listeria monocytogenes: Clinical and experimental update J Infect Dis 2002, 185(suppl 1):S18-24. 10.1086/338465 11865436